Simvastatin exhibited greater cytotoxicity against MDA-MB-231 cells, a type of triple-negative breast cancer model, than MCF-7 cells, a type of normal breast cancer, due to higher HMG-CoA-reductase expression. This evidence concerns the gene HMGCR and breast cancer.